{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:02:18Z","timestamp":1787918538247,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Delaware\u2019s 2022 Summer Fellows Undergraduate Research Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Eat Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Relapse rates in Anorexia Nervosa (AN) remain high, warranting exploration of further treatments. Cannabinoid agonists are of interest as they have shown successful outcomes in the treatment of associated conditions, such as post-traumatic stress disorder. This scoping review explores the endocannabinoid system (ECS), benefits\/harms\/null effects of cannabinoid treatment, and harms of cannabis use in AN.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>PubMed, PsycINFO, Cochrane, and Web of Science were searched for studies published between 2010 and August 2023, with human participants that explored the ECS, cannabinoid treatment, or cannabis use, and included 1 or more keywords for both cannabis and AN in the title and or abstract. Reports describing secondary anorexia, reports not available in English, grey literature, reports combining data from AN with other conditions, and reports only reporting the prevalence of cannabis abuse\/dependence were excluded. Data were extracted from 17 reports (n\u2009=\u200915 studies). For the ECS, outcomes included genetics such as allele expression related to the ECS, cannabinoid receptor availability, and circulating levels of endocannabinoids. For benefits\/harms\/null effects of cannabinoid treatment, outcomes included changes in weight, eating disorder (ED) symptoms, physical activity (PA), and hormones. For harms of cannabis use, outcomes included genetics related to cannabis use disorder and associations between cannabis use and ED symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eight studies (n\u2009=\u20098 reports) found abnormalities in the ECS in AN including expression of related alleles, genotypes, and haplotypes, availability of cannabinoid receptors, and levels of endocannabinoids. Three studies (n\u2009=\u20095 reports) found benefits\/harms\/null effects of cannabinoid treatment. Benefits included weight gain, improved ED symptoms and reduced PA, while null effects included no changes in weight or ED symptoms, and harms included increased PA and lowered adipose hormones. Four studies (n\u2009=\u20094 reports) expanded upon harms of cannabis use, including genetic predispositions to cannabis use disorder, and compensatory behaviors related to cannabis use.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Limited evidence suggests that abnormalities in the ECS in AN may render cannabis a potential treatment for weight restoration and associated symptoms. Future research may wish to investigate individualized dosing approaches to maximize beneficial effects while minimizing harms.<\/jats:p>\n                <jats:p>Level II Evidence: Scoping Review.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40337-023-00887-9","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T11:02:09Z","timestamp":1697713329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The relationship between cannabis and anorexia nervosa: a scoping review"],"prefix":"10.1186","volume":"11","author":[{"given":"Chloe I.","family":"Rogers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly R.","family":"Pacanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"issue":"1","key":"887_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40337-017-0145-3","volume":"5","author":"SS Khalsa","year":"2017","unstructured":"Khalsa SS, Portnoff LC, McCurdy-McKinnon D, Feusner JD. What happens after treatment? A systematic review of relapse, remission, and recovery in anorexia nervosa. J Eat Disord. 2017;5(1):20. https:\/\/doi.org\/10.1186\/s40337-017-0145-3","journal-title":"J Eat Disord"},{"issue":"4","key":"887_CR2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/erv.2683","volume":"27","author":"E van den Berg","year":"2019","unstructured":"van den Berg E, Houtzager L, de Vos J, Daemen I, Katsaragaki G, Karyotaki E, et al. Meta-analysis on the efficacy of psychological treatments for anorexia nervosa. Eur Eat Disord Rev J Eat Disord Assoc. 2019;27(4):331\u201351.\u00a0https:\/\/doi.org\/10.1002\/erv.2683","journal-title":"Eur Eat Disord Rev J Eat Disord Assoc"},{"issue":"1","key":"887_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.clinthera.2020.11.006","volume":"43","author":"AF Muratore","year":"2021","unstructured":"Muratore AF, Attia E. Current therapeutic approaches to anorexia nervosa: State of the art. Clin Ther. 2021;43(1):85\u201394. https:\/\/doi.org\/10.1016\/j.clinthera.2020.11.006.","journal-title":"Clin Ther"},{"issue":"5","key":"887_CR4","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s40519-019-00769-7","volume":"25","author":"C Klastrup","year":"2019","unstructured":"Klastrup C, Fr\u00f8lich J, Winkler LA-D, St\u00f8ving RK. Hunger and satiety perception in patients with severe anorexia nervosa. Eating Weight Disorders Studi Anorexia Bulimia Obes. 2019;25(5):1347\u201355. https:\/\/doi.org\/10.1007\/s40519-019-00769-7.","journal-title":"Eating Weight Disorders Studi Anorexia Bulimia Obes"},{"key":"887_CR5","doi-asserted-by":"publisher","unstructured":"Aulinas A, Plessow F, Pulumo RL, Asanza E, Mancuso CJ, Slattery M, et al. Disrupted Oxytocin-Appetite Signaling in Females With Anorexia Nervosa. J Clin Endocrinol Metab. 2019;104(10):4931\u201340. https:\/\/doi.org\/10.1210\/jc.2019-00926","DOI":"10.1210\/jc.2019-00926"},{"issue":"5","key":"887_CR6","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1021\/acschemneuro.8b00651","volume":"10","author":"SD Banister","year":"2019","unstructured":"Banister SD, Arnold JC, Connor M, Glass M, McGregor IS. Dark classics in chemical neuroscience: \u0394(9)-tetrahydrocannabinol. ACS Chem Neurosci. 2019;10(5):2160\u201375.\u00a0https:\/\/doi.org\/10.1021\/acschemneuro.8b00651","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"887_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00406-019-00999-x","volume":"269","author":"E Hoch","year":"2019","unstructured":"Hoch E, Niemann D, von Keller R, Schneider M, Friemel CM, Preuss UW, et al. How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review. Eur Arch Psychiatry Clin Neurosci. 2019;269(1):87\u2013105. https:\/\/doi.org\/10.1007\/s00406-019-00999-x.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"16","key":"887_CR8","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1111\/bph.13892","volume":"174","author":"M Scherma","year":"2017","unstructured":"Scherma M, Satta V, Collu R, Boi MF, Usai P, Fratta W, et al. Cannabinoid CB(1)\/CB(2) receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia. Br J Pharmacol. 2017;174(16):2682\u201395.\u00a0https:\/\/doi.org\/10.1111\/bph.13892","journal-title":"Br J Pharmacol"},{"key":"887_CR9","doi-asserted-by":"publisher","unstructured":"Lu HC, Mackie K. Review of the Endocannabinoid System. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6(6):607-615. https:\/\/doi.org\/10.1016\/j.bpsc.2020.07.016.","DOI":"10.1016\/j.bpsc.2020.07.016"},{"key":"887_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3389\/fpsyt.2020.00315","volume":"11","author":"F Navarrete","year":"2020","unstructured":"Navarrete F, Garc\u00eda-Guti\u00e9rrez MS, Jurado-Barba R, Rubio G, Gasparyan A, Austrich-Olivares A, et al. Endocannabinoid system components as potential biomarkers in psychiatry. Front Psychiatry. 2020;11:315. https:\/\/doi.org\/10.3389\/fpsyt.2020.00315","journal-title":"Front Psychiatry"},{"key":"887_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fnbeh.2011.00063","volume":"5","author":"EM Marco","year":"2011","unstructured":"Marco EM, Garc\u00eda-Guti\u00e9rrez MS, Berm\u00fadez-Silva FJ, Moreira FA, Guimar\u00e3es F, Manzanares J, et al. Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects. Front Behav Neurosci. 2011;5:63.\u00a0https:\/\/doi.org\/10.3389\/fnbeh.2011.00063","journal-title":"Front Behav Neurosci"},{"issue":"1","key":"887_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s40337-021-00516-3","volume":"9","author":"DJ Devoe","year":"2021","unstructured":"Devoe DJ, Dimitropoulos G, Anderson A, Bahji A, Flanagan J, Soumbasis A, et al. The prevalence of substance use disorders and substance use in anorexia nervosa: a systematic review and meta-analysis. J Eat Disord. 2021;9(1):161.\u00a0https:\/\/doi.org\/10.1186\/s40337-021-00516-3.","journal-title":"J Eat Disord"},{"issue":"1","key":"887_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s13181-016-0595-z","volume":"13","author":"CJ Sorensen","year":"2017","unstructured":"Sorensen CJ, DeSanto K, Borgelt L, Phillips KT, Monte AA. Cannabinoid hyperemesis syndrome: diagnosis, pathophysiology, and treatment-a systematic review. J Med Toxicol Off J Am Coll Med Toxicol. 2017;13(1):71\u201387.\u00a0https:\/\/doi.org\/10.1007\/s13181-016-0595-z","journal-title":"J Med Toxicol Off J Am Coll Med Toxicol"},{"issue":"2","key":"887_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s40519-020-00891-x","volume":"26","author":"EV Rosager","year":"2021","unstructured":"Rosager EV, M\u00f8ller C, Sj\u00f6gren M. Treatment studies with cannabinoids in anorexia nervosa: a systematic review. Eat Weight Disord EWD. 2021;26(2):407\u201315.\u00a0https:\/\/doi.org\/10.1007\/s40519-020-00891-x","journal-title":"Eat Weight Disord EWD"},{"issue":"10","key":"887_CR15","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","volume":"18","author":"MDJ Peters","year":"2020","unstructured":"Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020;18(10):2119.\u00a0https:\/\/doi.org\/10.11124\/JBIES-20-00167","journal-title":"JBI Evid Synth"},{"issue":"7","key":"887_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373.\u00a0https:\/\/doi.org\/10.7326\/M18-0850","journal-title":"Ann Intern Med"},{"issue":"2","key":"887_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/syn.20821","volume":"65","author":"H Ishiguro","year":"2011","unstructured":"Ishiguro H, Onaivi ES, Horiuchi Y, Imai K, Komaki G, Ishikawa T, et al. Functional polymorphism in the GPR55 gene is associated with anorexia nervosa. Synap N Y N. 2011;65(2):103\u20138.\u00a0https:\/\/doi.org\/10.1002\/syn.20821","journal-title":"Synap N Y N"},{"issue":"4","key":"887_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/mgg3.69","volume":"2","author":"T Ando","year":"2014","unstructured":"Ando T, Tamura N, Mera T, Morita C, Takei M, Nakamoto C, et al. Association of the c.385C>A (p.Pro129Thr) polymorphism of the fatty acid amide hydrolase gene with anorexia nervosa in the Japanese population. Mol Genet Genomic Med. 2014;2(4):313\u20138.\u00a0https:\/\/doi.org\/10.1002\/mgg3.69","journal-title":"Mol Genet Genomic Med"},{"issue":"8","key":"887_CR19","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s40519-021-01106-7","volume":"26","author":"LM Gonz\u00e1lez","year":"2021","unstructured":"Gonz\u00e1lez LM, Garc\u00eda-Herr\u00e1iz A, Mota-Zamorano S, Flores I, Albuquerque D, Gervasini G. Variability in cannabinoid receptor genes is associated with psychiatric comorbidities in anorexia nervosa. Eat Weight Disord EWD. 2021;26(8):2597\u2013606.\u00a0https:\/\/doi.org\/10.1007\/s40519-021-01106-7","journal-title":"Eat Weight Disord EWD"},{"issue":"8","key":"887_CR20","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.biopsych.2011.05.010","volume":"70","author":"N G\u00e9rard","year":"2011","unstructured":"G\u00e9rard N, Pieters G, Goffin K, Bormans G, Van Laere K. Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa. Biol Psychiatry. 2011;70(8):777\u201384.\u00a0https:\/\/doi.org\/10.1016\/j.biopsych.2011.05.010","journal-title":"Biol Psychiatry"},{"issue":"107","key":"887_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2021.110243","volume":"20","author":"FI Tam","year":"2021","unstructured":"Tam FI, Steding J, Steinh\u00e4user JL, Ritschel F, Gao W, Weidner K, et al. Hair endocannabinoid concentrations in individuals with acute and weight-recovered anorexia nervosa. Prog Neuropsychopharmacol Biol Psychiatry. 2021;20(107): 110243.\u00a0https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110243","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"887_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3945\/ajcn.114.096164","volume":"101","author":"AM Monteleone","year":"2015","unstructured":"Monteleone AM, Di Marzo V, Aveta T, Piscitelli F, Dalle Grave R, Scognamiglio P, et al. Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa. Am J Clin Nutr. 2015;101(2):262\u20139.\u00a0https:\/\/doi.org\/10.3945\/ajcn.114.096164","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"887_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/erv.2709","volume":"28","author":"M Piccolo","year":"2020","unstructured":"Piccolo M, Claussen MC, Bluemel S, Schumacher S, Cronin A, Fried M, et al. Altered circulating endocannabinoids in anorexia nervosa during acute and weight-restored phases: a pilot study. Eur Eat Disord Rev J Eat Disord Assoc. 2020;28(1):46\u201354.\u00a0https:\/\/doi.org\/10.1002\/erv.2709.","journal-title":"Eur Eat Disord Rev J Eat Disord Assoc"},{"issue":"1","key":"887_CR24","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2023.2411","volume":"66","author":"I Baenas","year":"2023","unstructured":"Baenas I, Miranda-Olivos R, Granero R, Sol\u00e9-Morata N, S\u00e1nchez I, Pastor A, et al. Association of anandamide and 2-arachidonoylglycerol concentrations with clinical features and body mass index in eating disorders and obesity. Eur Psychiatry J Assoc Eur Psychiatr. 2023;66(1): e49.\u00a0https:\/\/doi.org\/10.1192\/j.eurpsy.2023.2411","journal-title":"Eur Psychiatry J Assoc Eur Psychiatr"},{"issue":"1","key":"887_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/npp.2017.130","volume":"43","author":"CJ Hillard","year":"2018","unstructured":"Hillard CJ. Circulating endocannabinoids: from whence do they come and where are they going? Neuropsychopharmacology. 2018;43(1):155\u201372.\u00a0https:\/\/doi.org\/10.1038\/npp.2017.130","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"887_CR26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s13668-022-00436-x","volume":"11","author":"N Aguilera Vasquez","year":"2022","unstructured":"Aguilera Vasquez N, Nielsen DE. The endocannabinoid system and eating behaviours: a review of the current state of the evidence. Curr Nutr Rep. 2022;11(4):665\u201374.\u00a0https:\/\/doi.org\/10.1007\/s13668-022-00436-x.","journal-title":"Curr Nutr Rep"},{"issue":"1","key":"887_CR27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/eat.22173","volume":"47","author":"A Andries","year":"2014","unstructured":"Andries A, Frystyk J, Flyvbjerg A, St\u00f8ving RK. Dronabinol in severe, enduring anorexia nervosa: a randomized controlled trial. Int J Eat Disord. 2014;47(1):18\u201323.\u00a0https:\/\/doi.org\/10.1002\/eat.22173.","journal-title":"Int J Eat Disord"},{"issue":"1","key":"887_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40519-014-0132-5","volume":"20","author":"A Andries","year":"2015","unstructured":"Andries A, Gram B, St\u00f8ving RK. Effect of dronabinol therapy on physical activity in anorexia nervosa: a randomised, controlled trial. Eat Weight Disord EWD. 2015;20(1):13\u201321.\u00a0https:\/\/doi.org\/10.1007\/s40519-014-0132-5.","journal-title":"Eat Weight Disord EWD"},{"issue":"5","key":"887_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ghir.2015.07.006","volume":"25","author":"A Andries","year":"2015","unstructured":"Andries A, Frystyk J, Flyvbjerg A, St\u00f8ving RK. Changes in IGF-I, urinary free cortisol and adipokines during dronabinol therapy in anorexia nervosa: Results from a randomised, controlled trial. Growth Horm IGF Res Off J Growth Horm Res Soc Int IGF Res Soc. 2015;25(5):247\u201352.\u00a0https:\/\/doi.org\/10.1016\/j.ghir.2015.07.006","journal-title":"Growth Horm IGF Res Off J Growth Horm Res Soc Int IGF Res Soc"},{"issue":"3","key":"887_CR30","first-page":"44","volume":"54","author":"Y Avraham","year":"2017","unstructured":"Avraham Y, Latzer Y, Hasid D, Berry EM. The impact of \u03949-THC on the psychological symptoms of anorexia nervosa: a pilot study. Isr J Psychiatry. 2017;54(3):44\u201351.","journal-title":"Isr J Psychiatry"},{"issue":"2","key":"887_CR31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/eat.22804","volume":"51","author":"H Graap","year":"2018","unstructured":"Graap H, Erim Y, Paslakis G. The effect of dronabinol in a male patient with anorexia nervosa suffering from severe acute urge to be physically active. Int J Eat Disord. 2018;51(2):180\u20133.\u00a0https:\/\/doi.org\/10.1002\/eat.22804","journal-title":"Int J Eat Disord"},{"issue":"1\u20132","key":"887_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.drugalcdep.2012.08.001","volume":"128","author":"R Vandrey","year":"2013","unstructured":"Vandrey R, Stitzer ML, Mintzer MZ, Huestis MA, Murray JA, Lee D. The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug Alcohol Depend. 2013;128(1\u20132):64\u201370.\u00a0https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.08.001","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"887_CR33","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/nu12010183","volume":"12","author":"R Melissa","year":"2020","unstructured":"Melissa R, Lama M, Laurence K, Sylvie B, Jeanne D, Odile V, et al. Physical activity in eating disorders: a systematic review. Nutrients. 2020;12(1):183.\u00a0https:\/\/doi.org\/10.3390\/nu12010183","journal-title":"Nutrients"},{"issue":"263","key":"887_CR34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.psychres.2017.07.049","volume":"1","author":"F Brambilla","year":"2018","unstructured":"Brambilla F, Santonastaso P, Caregaro L, Favaro A. Growth hormone and insulin-like growth factor 1 secretions in eating disorders: Correlations with psychopathological aspects of the disorders. Psychiatry Res. 2018;1(263):233\u20137.\u00a0https:\/\/doi.org\/10.1016\/j.psychres.2017.07.049","journal-title":"Psychiatry Res"},{"issue":"3","key":"887_CR35","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1017\/S0033291719003362","volume":"51","author":"C Hjorth\u00f8j","year":"2021","unstructured":"Hjorth\u00f8j C, Uddin MJ, Wimberley T, Dalsgaard S, Hougaard DM, B\u00f8rglum A, et al. No evidence of associations between genetic liability for schizophrenia and development of cannabis use disorder. Psychol Med. 2021;51(3):479\u201384.\u00a0https:\/\/doi.org\/10.1017\/S0033291719003362.","journal-title":"Psychol Med"},{"key":"887_CR36","doi-asserted-by":"publisher","unstructured":"Ihm HK, Kim H, Kim J, Park WY, Kang HS, Park J, et al. Genetic network structure of 13 psychiatric disorders in the general population. Eur Arch Psychiatry Clin Neurosci. 2023. https:\/\/doi.org\/10.1007\/s00406-023-01601-1.","DOI":"10.1007\/s00406-023-01601-1"},{"issue":"8","key":"887_CR37","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/eat.22515","volume":"49","author":"TD Brewerton","year":"2016","unstructured":"Brewerton TD, Anderson O. Cannabinoid hyperemesis syndrome masquerading as an eating disorder. Int J Eat Disord. 2016;49(8):826\u20139.\u00a0https:\/\/doi.org\/10.1002\/eat.22515","journal-title":"Int J Eat Disord"},{"issue":"3","key":"887_CR38","doi-asserted-by":"publisher","first-page":"272","DOI":"10.5455\/bcp.20121130090627","volume":"23","author":"S Karayilan","year":"2013","unstructured":"Karayilan S, Erol A. Anorexia nervosa and cannabis abuse: a case report. Klin Psikofarmakol B\u00fcl Bull Clin Psychopharmacol. 2013;23(3):272\u20135.\u00a0https:\/\/doi.org\/10.5455\/bcp.20121130090627.","journal-title":"Klin Psikofarmakol B\u00fcl Bull Clin Psychopharmacol"},{"key":"887_CR39","doi-asserted-by":"publisher","unstructured":"Feeding and Eating Disorders. In: Diagnostic and Statistical Manual of Mental Disorders [Internet]. American Psychiatric Association Publishing; 2022 [cited 2023 Aug 24]. (DSM Library). https:\/\/doi.org\/10.1176\/appi.books.9780890425787.x10_Feeding_and_Eating_Disorders","DOI":"10.1176\/appi.books.9780890425787.x10_Feeding_and_Eating_Disorders"},{"key":"887_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2013.00130","author":"RJM Niesink","year":"2013","unstructured":"Niesink RJM, van Laar M. Does cannabidiol protect against adverse psychological effects of THC? Front Psychiatry. 2013. https:\/\/doi.org\/10.3389\/fpsyt.2013.00130.","journal-title":"Front Psychiatry"},{"key":"887_CR41","doi-asserted-by":"publisher","unstructured":"Frank GKW, Shott ME, DeGuzman MC. Recent advances in understanding anorexia nervosa. F1000Research. 2019;8:F1000 Faculty Rev-504. https:\/\/doi.org\/10.12688\/f1000research.17789.1.","DOI":"10.12688\/f1000research.17789.1"}],"container-title":["Journal of Eating Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40337-023-00887-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40337-023-00887-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40337-023-00887-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T07:20:56Z","timestamp":1700292056000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeatdisord.biomedcentral.com\/articles\/10.1186\/s40337-023-00887-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["887"],"URL":"https:\/\/doi.org\/10.1186\/s40337-023-00887-9","relation":{},"ISSN":["2050-2974"],"issn-type":[{"value":"2050-2974","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]},"assertion":[{"value":"2 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"186"}}